Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  G. Severi,et al.  Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study. , 2020, medRxiv.

[3]  Christina C. Chang,et al.  High Seroprevalence of Anti-SARS-CoV-2 Antibodies in Chelsea, Massachusetts , 2020, The Journal of infectious diseases.

[4]  Samuel M. Brown,et al.  Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[5]  P. Pelosi,et al.  Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors , 2020, Journal of clinical medicine.

[6]  M. Borhany,et al.  Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan , 2020, Transfusion and Apheresis Science.

[7]  P. Cieslak,et al.  Notes from the Field: Seroprevalence Estimates of SARS-CoV-2 Infection in Convenience Sample — Oregon, May 11–June 15, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[8]  M. Margaglione,et al.  Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS‐CoV‐2 , 2020, Journal of medical virology.

[9]  E. Gratacós,et al.  Seroprevalence and presentation of SARS-CoV-2 in pregnancy , 2020, The Lancet.

[10]  B. Farber,et al.  Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area. , 2020, JAMA.

[11]  M. Kelsey,et al.  Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust , 2020, Infection Control & Hospital Epidemiology.

[12]  M. Zimmerman,et al.  Seroprevalence of SARS-CoV-2 Antibodies Among Healthcare Workers With Differing Levels of COVID-19 Patient Exposure. , 2020, Infection control and hospital epidemiology.

[13]  E. Petinaki,et al.  Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[14]  P. Kelleher,et al.  High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening. , 2020, Journal of the American Society of Nephrology : JASN.

[15]  Jeffrey S. Morris,et al.  SARS-CoV-2 seroprevalence among parturient women in Philadelphia , 2020, Science Immunology.

[16]  Jungsang Ryou,et al.  Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea , 2020, Journal of Korean medical science.

[17]  M. Plebani,et al.  SARS-CoV-2 serosurvey in health care workers of the Veneto Region , 2020, medRxiv.

[18]  M. Rayment,et al.  Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study , 2020, The Lancet Respiratory Medicine.

[19]  Brian E. Dixon,et al.  Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[20]  George Turabelidze,et al.  Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. , 2020, JAMA internal medicine.

[21]  Kathryn T. Morrison,et al.  High Community SARS-CoV-2 Antibody Seroprevalence in a Ski Resort Community, Blaine County, Idaho, US. Preliminary Results , 2020, medRxiv.

[22]  R. San Juan,et al.  SARS-CoV-2 in pregnancy: characteristics and outcomes of hospitalized and non-hospitalized women due to COVID-19 , 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[23]  S. Unlu,et al.  A pandemic center’s experience of managing pregnant women with COVID‐19 infection in Turkey: A prospective cohort study , 2020, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[24]  J. Weinstein,et al.  COVID-19 Outbreak in an Urban Hemodialysis Unit , 2020, American Journal of Kidney Diseases.

[25]  P. Gallian,et al.  Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors , 2020, Antiviral Research.

[26]  M. Valenzuela,et al.  SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Sung‐Han Kim,et al.  Clinical application of rapid diagnostic test kit for SARS-CoV-2 antibodies into the field of patient care , 2020, Journal of Microbiology, Immunology and Infection.

[28]  Robert L. Goldstone,et al.  Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers , 2020, The Lancet.

[29]  I. Sam,et al.  Low postpandemic wave SARS‐CoV‐2 seroprevalence in Kuala Lumpur and Selangor, Malaysia , 2020, Journal of medical virology.

[30]  B. Horta,et al.  Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil , 2020, Nature Medicine.

[31]  M. Hernán,et al.  Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study , 2020, The Lancet.

[32]  B. Meyer,et al.  SARS-CoV-2 seroprevalence in COVID-19 hotspots , 2020, The Lancet.

[33]  Jing Huang,et al.  Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China , 2020, American Journal of Kidney Diseases.

[34]  G. Werneck,et al.  Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil , 2020, Revista de saude publica.

[35]  A. Chughtai,et al.  Frequency of COVID-19 IgG Antibodies among Special Police Squad Lahore, Pakistan. , 2020, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP.

[36]  N. Clumeck,et al.  Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staff , 2020, Journal of Hospital Infection.

[37]  P. Hosseinpour,et al.  Coronavirus Disease 2019 (COVID-19): A Systematic Review of Pregnancy and the Possibility of Vertical Transmission , 2020, Journal of reproduction & infertility.

[38]  W. Ko,et al.  Anosmia and olfactory tract neuropathy in a case of COVID-19 , 2020, Journal of Microbiology, Immunology and Infection.

[39]  Peng Li,et al.  Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19 , 2020, Clinica Chimica Acta.

[40]  P. Vermeersch,et al.  Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. , 2020, JAMA.

[41]  A. Flahault,et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.

[42]  W. Ko,et al.  In vitro diagnostics of coronavirus disease 2019: Technologies and application , 2020, Journal of Microbiology, Immunology and Infection.

[43]  Chunbao Xie,et al.  Author Correction: Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China , 2020, Nature Medicine.

[44]  Yong Chen,et al.  High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients , 2020, Journal of Infection.

[45]  D. Cereda,et al.  Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[46]  S. Yıldırım,et al.  Incidence and Immunologic Analysis of Coronavirus Disease (COVID-19) in Hemodialysis Patients:A Single-Center Experience. , 2020, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

[47]  David R. Holtgrave,et al.  Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York , 2020, Annals of Epidemiology.

[48]  J. Bloom,et al.  Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak , 2020, medRxiv.

[49]  C. Soo,et al.  Bonuses and pitfalls of a paperless drive-through screening and COVID-19: A field report , 2020, Journal of Microbiology, Immunology and Infection.

[50]  Gregory M. Goldgof,et al.  SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay Area , 2020, medRxiv.

[51]  Daniel Eichner,et al.  Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. , 2020, JAMA.

[52]  A. Kribben,et al.  SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients , 2020, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[53]  D. Rader,et al.  SARS-CoV-2 Seroprevalence Among Parturient Women , 2020, medRxiv.

[54]  Chuan Qin,et al.  Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China , 2020, JAMA network open.

[55]  M. Koopmans,et al.  Prevalence and Clinical Presentation of Health Care Workers With Symptoms of Coronavirus Disease 2019 in 2 Dutch Hospitals During an Early Phase of the Pandemic , 2020, JAMA network open.

[56]  Jens K. Boldsen,et al.  Estimation of SARS-CoV-2 Infection Fatality Rate by Real-time Antibody Screening of Blood Donors , 2020, medRxiv.

[57]  Zhan Gao,et al.  A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2 , 2020, Journal of Microbiology, Immunology and Infection.

[58]  B. Graham,et al.  Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance , 2020, bioRxiv.

[59]  D. Lendrem,et al.  First experience of COVID-19 screening of health-care workers in England , 2020, The Lancet.

[60]  W. Ko,et al.  SARS-CoV-2 and COVID-19 , 2020, Journal of Microbiology, Immunology and Infection.

[61]  C. Evans,et al.  Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[62]  Jianli Wu,et al.  Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study , 2020, The Lancet Infectious Diseases.

[63]  W. Ko,et al.  Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status , 2020, International Journal of Antimicrobial Agents.

[64]  D. Bassler,et al.  COVID-19 in pregnant women , 2020, The Lancet Infectious Diseases.

[65]  W. Ko,et al.  Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths , 2020, Journal of Microbiology, Immunology and Infection.

[66]  N. Dey.  COVID-19 Outbreak , 2020, Data Analytics for Pandemics.

[67]  Yhu-Chering Huang,et al.  Are children less susceptible to COVID-19? , 2020, Journal of Microbiology, Immunology and Infection.

[68]  W. Ko,et al.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges , 2020, International Journal of Antimicrobial Agents.

[69]  Huixia Yang,et al.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records , 2020, The Lancet.

[70]  Yan Zhao,et al.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.

[71]  Jing Zhao,et al.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia , 2020, The New England journal of medicine.

[72]  Dara Grennan.  What Is a Pandemic? , 2019, JAMA.

[73]  A. Danchin,et al.  The Severe Acute Respiratory Syndrome , 2003, The New England journal of medicine.

[74]  B. Hagberg,et al.  CLINICAL CHARACTERISTICS , 1972 .

[75]  Andres Chang.  Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia , 2022 .

[76]  T. Tabuchi,et al.  Coronavirus Disease , 2021, Encyclopedia of the UN Sustainable Development Goals.

[77]  B. Cakal.  Antibody Responses Against SARS-Cov-2 in COVID-19 and Serological Assays , 2020, Turkiye Klinikleri Journal of Health Sciences.

[78]  P. Tulkens,et al.  International Journal of Antimicrobial Agents , 2022 .